EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of short‐course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor‐positive, HER2 ‐negative breast cancer

Claudia Grosse iD, Alexandra Grosse iD, Petar Noack, Caroline Ines Preuss, Heike Kathleen Schwarz, Bruno Schneeweiss, Thomas Gitter, Peter Schrenk, Rupert Langer iD

Histopathology · 2026

DOI: 10.1111/his.70203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2026. Verfasst von Claudia Grosse und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology and Molecular Pathology, Johannes Kepler University Linz, Kepler University Hospital GmbH, Linz, Austria. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Hormonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Short‐term preoperative endocrine therapy (ET) is increasingly used in oestrogen receptor (ER)‐positive, HER2‐negative breast cancer as a functional test of endocrine sensitivity. We aimed to characterise histomorphological and immunophenotypic changes following preoperative ET and to identify predictors of endocrine response, defined as post‐treatment Ki67 ≤ 10%. Methods and results In this retrospective single‐centre study, 180 patients treated with short‐course preoperative ET (median duration 29 days) were compared with 151 patients undergoing primary surgery without ET. Paired biopsy and resection specimens were assessed for histological features, stromal proportion, stromal tumour‐infiltrating lymphocytes (strTILs) and expression of ER, progesterone receptor (PR), HER2 and Ki67. Genomic risk was determined using the MammaPrint assay. Preoperative ET was associated with a significant reduction in tumour proliferation, with 73.9% of cases showing post‐treatment Ki67 ≤ 10% compared with none in controls ( P < 0.001). Histological grade decreased in 36.7% of ET‐treated tumours versus 7.9% of controls ( P < 0.001), predominantly reflecting reduced mitotic activity. ER expression remained stable, whereas PR expression decreased more frequently following ET ( P < 0.001) and was independently associated with Ki67‐defined response. HER2‐low status was more frequently observed after ET ( P < 0.001), but HER2 expression and microenvironmental parameters, including strTILs, were not associated with response. High genomic risk was independently associated with a lower likelihood of achieving post‐treatment Ki67 ≤ 10% ( P < 0.001).

Conclusions

Short‐course preoperative ET induces rapid and reproducible morphological and immunophenotypic changes in ER‐positive, HER2‐negative breast cancer. Ki67‐defined response is associated with genomic risk and PR expression, whereas microenvironmental features appear to have limited predictive value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAntineoplastic Agents, HormonalHumansFemaleErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenMiddle AgedRetrospective StudiesAdultAgedKi-67 AntigenImmunohistochemistryNeoadjuvant TherapyReceptors, ProgesteroneBiomarkers, TumorAged, 80 and over

Stichwörter der Autor:innen

Ki67MammaPrintbreast cancerpreoperative endocrine therapyprogesterone receptortumour grading

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenERBB2 protein, humanAntineoplastic Agents, HormonalKi-67 AntigenReceptors, ProgesteroneBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Pathology and Molecular Pathology, Johannes Kepler University Linz, Kepler University Hospital GmbH, Linz, Austria.
  • Pathology Medica Enge AG, Zurich, Switzerland.
  • Department of Gynaecology, Obstetrics and Gynaecological Endocrinology, Johannes Kepler University Linz, Kepler University Hospital GmbH, Linz, Austria.
  • Department of Haematology and Oncology, Johannes Kepler University Linz, Kepler University Hospital GmbH, Linz, Austria.
  • Central Radiology Institute, Johannes Kepler University Linz, Kepler University Hospital GmbH, Linz, Austria.
  • Department of General and Visceral Surgery, Johannes Kepler University Linz, Kepler University Hospital GmbH, Linz, Austria.

ORCID-Profile: Claudia Grosse, Alexandra Grosse, Rupert Langer

Zitieren

APA

Grosse, C., Grosse, A., Noack, P., Preuss, C. I., Schwarz, H. K., Schneeweiss, B., Gitter, T., Schrenk, P., & Langer, R. (2026). Effects of short‐course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor‐positive, HER2 ‐negative breast cancer. Histopathology. https://doi.org/10.1111/his.70203

Vancouver

Grosse C, Grosse A, Noack P, Preuss CI, Schwarz HK, Schneeweiss B, et al. Effects of short‐course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor‐positive, HER2 ‐negative breast cancer. Histopathology. 2026. doi:10.1111/his.70203

BibTeX
@article{Grosse2026,
  author = {Grosse, Claudia and Grosse, Alexandra and Noack, Petar and Preuss, Caroline Ines and Schwarz, Heike Kathleen and Schneeweiss, Bruno and Gitter, Thomas and Schrenk, Peter and Langer, Rupert},
  title = {Effects of short‐course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor‐positive, HER2 ‐negative breast cancer},
  journal = {Histopathology},
  year = {2026},
  doi = {10.1111/his.70203}
}
Kostenlos starten →